Global Pharmerging Market to Grow at a CAGR of 12.88% During 2017-2021 - Key Vendors (AstraZeneca, GlaxoSmithKline, Pfizer, Sanofi and Novartis) has recently announced the addition of a market study “Global Pharmerging Markets 2017-2021”, is a comparative analysis of the global market.


Albany, NY -- (SBWIRE) -- 02/06/2017 -- About Pharmerging

The immense growth potential in pharmerging market has driven large multinational pharmaceutical companies to focus on these regions by pursuing organic as well as in-organic routes. To make in-roads into the new geography, the large players usually take in-organic route through strategic expansion initiatives such as acquisitions and alliances. For instance, in December 2015, AstraZeneca entered into a deal with WuXi to acquire its biologics manufacturing facilities in China to expand locally.

Technavios analysts forecast the global pharmerging market to grow at a CAGR of 12.88% during the period 2017-2021.

View Full Report at

Covered in this report

The report covers the present scenario and the growth prospects of the global pharmerging market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of pharmaceutical drugs in pharmerging markets, which are further divided into Tier I, II and III.

The market is divided into the following segments based on geography:

Tier 1
Tier 2
Tier 3

Technavio's report, Global Pharmerging Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

Download The sample Copy Of This Report:

Other prominent vendors
Abbott Laboratories
Alexion Pharmaceuticals
Astellas Pharma
Boehringer Ingelheim
Bristol-Myers Squibb
CSL Behring
Daiichi Sankyo
Dainippon Sumitomo Pharma
Eli Lilly
Endo Health Pharmaceuticals
F. Hoffmann-La Roche
H. Lundbeck
Johnson & Johnson
Kyowa Hakko Kirin
Mallinckrodt Pharmaceuticals
Mitsubishi Tanabe Pharma
Novo Nordisk
STADA Arzneimittel
Sun Pharmaceutical
Takeda Pharma
Teva Pharmaceutical Industries
Valeant Pharmaceuticals

Market driver
Limitations in developed economies fuels demand in emerging economies
For a full, detailed list, view our report

Market challenge
Stringent price control and generic -centric usage lead to value erosion
For a full, detailed list, view our report

Market trend
Potential of new countries in emerging markets
For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

About is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Read our latest Press Releases at


State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
USA: Canada Toll Free: 866-997-4948
Follow us on LinkedIn: